Zoono Group Limited (ZNO) Share Price & Analysis

11 Followers

ZNO Stock Chart & Stats

A$0.04A$0.00(0.00%)

At close: Nov 05 4:00 PM GMT+11

Day’s Range: AUD 0.04 - AUD 0.04
52-Week Range: AUD 0.04 - AUD 0.18
Previous Close: AUD 0.04
Volume: N/A
Average Volume (3M): 78.10K
Market Cap: AUD 18.16M
Enterprise Value: AUD 22.01M
Total Cash (Recent Filing): AUD 220.15K
Total Debt (Recent Filing): AUD 298.54K
Price to Earnings (P/E): ―
Beta: 0.32
Next Earnings: Feb 25, 2027 (Est.)
EPS Estimate: N/A
Last Dividend Ex-Date: Sep 04, 2020
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Revenue And Gross Margin Recovery

The sharp 2026 revenue rebound and return to positive gross margin indicate improved commercial traction and operating execution. If maintained, stronger sales and product-level economics can provide a foundation for scale, reinvestment, and eventual profitability over the next several quarters.

Low Financial Leverage

Modest leverage reduces solvency pressure and limits the interest burden associated with debt-funded operations. This gives Zoono greater financial flexibility to support its antimicrobial product business and manage future volatility, even though operating losses remain a material constraint.

Proprietary Antimicrobial Platform

A proprietary technology platform can support differentiated products and a repeatable commercial model across hygiene, infection-control, and surface-treatment applications. Its use across healthcare, hospitality, transport, and consumer settings also provides multiple durable channels for market development.

Bears Say

Persistent Unprofitability

The revenue and gross-margin recovery has not yet translated into sustainable earnings. Five consecutive years of losses and deeply negative 2026 net margin suggest that operating costs remain too high relative to sales, limiting internal funding capacity and weakening the durability of the turnaround.

Ongoing Cash Burn

Persistent negative operating and free cash flow shows that reported improvements are not yet converting into cash generation. Continued cash burn can constrain investment in product commercialisation, increase reliance on external funding, and leave less flexibility to absorb execution setbacks.

Capital Erosion And Weak Returns

Repeated losses are eroding the equity base and producing sharply negative returns on shareholder capital. This weakens financial resilience over time, reduces the resources available to fund growth internally, and increases the importance of restoring profitable operations rather than relying only on sales recovery.

Zoono Group Limited News

Zoono Group Launches Speculative Rights Issue to Raise $1.6m

Zoono Group Limited ( ($AU:ZNO) ) just unveiled an announcement. Zoono Group Limited has launched a pro rata non-renounceable rights issue, offering eligible shareholders one new share for every ten

2w agoZNO

Zoono Group Plans Non-Renounceable Pro Rata Share Issue

An update from Zoono Group Limited ( ($AU:ZNO) ) is now available. Zoono Group Limited is an ASX-listed company operating in the hygiene and antimicrobial products sector. It develops and

2w agoZNO

Zoono launches rights issue to bolster capital while maintaining board control

The latest update is out from Zoono Group Limited ( ($AU:ZNO) ). Zoono Group Limited, a New Zealand-headquartered biotech firm, specialises in long-lasting antimicrobial sprays, wipes and foams for skin,

2w agoZNO

Zoono launches rights issue and placement to fund global product development

Zoono Group Limited ( ($AU:ZNO) ) has shared an update. Zoono Group Limited has launched a pro-rata non-renounceable rights issue, offering one new share for every ten held at $0.039

2w agoZNO

Zoono boosts capital with share placement and cleansing notice

Zoono Group Limited ( ($AU:ZNO) ) just unveiled an update. Zoono Group Limited has issued 6,410,256 new fully paid ordinary shares at $0.039 per share via a placement to an

2w agoZNO

Zoono Group Raises Fresh Capital via Single-Investor Share Placement

Zoono Group Limited ( ($AU:ZNO) ) just unveiled an update. Zoono Group Limited has applied for quotation of new ordinary fully paid shares on the ASX, under its existing code

2w agoZNO

Zoono Raises A$250,000 to Accelerate Food Shelf-Life Technology and Asian Expansion

An announcement from Zoono Group Limited ( ($AU:ZNO) ) is now available. Zoono Group Limited, a biotech firm specialising in durable antiviral and antibacterial products for consumer and industrial use,

2w agoZNO

Zoono Group Options Lapse, Trimming Potential Share Dilution

Zoono Group Limited ( ($AU:ZNO) ) just unveiled an update. Zoono Group Limited has reported the cessation of a tranche of listed options in its capital structure, specifically the ZNOAP

2w agoZNO

Zoono expands global shelf-life trials and shipping-container coatings

Zoono Group Limited ( ($AU:ZNO) ) has issued an announcement. Zoono Group reported continued progress in commercialising its shelf-life extension products during the quarter to 30 September 2026, highlighting broader

2w agoZNO

Zoono Directors Reshuffle Shareholdings to Signal Confidence

The latest update is out from Zoono Group Limited ( ($AU:ZNO) ). Zoono Group Limited has disclosed a change in directors’ interests after Non-Executive Director Marc Braterman sold 782,022 shares

1M agoZNO

ZNO FAQ

What was Zoono Group Limited’s price range in the past 12 months?

Zoono Group Limited lowest share price was AU$0.04 and its highest was AU$0.18 in the past 12 months.

What is Zoono Group Limited’s market cap?

Zoono Group Limited’s market cap is AU$18.16M.

When is Zoono Group Limited’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Zoono Group Limited’s earnings last quarter?

Zoono Group Limited released its earnings results on Aug 20, 2026. The company reported -AU$0.001 earnings per share for the quarter.

Is Zoono Group Limited overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Zoono Group Limited pay dividends?

Zoono Group Limited pays a Notavailable dividend of AU$0.03 which represents an annual dividend yield of ―. See more information on Zoono Group Limited dividends here

What is Zoono Group Limited’s EPS estimate?

Zoono Group Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Zoono Group Limited have?

Zoono Group Limited has 453,884,220 shares outstanding.

What happened to Zoono Group Limited’s price movement after its last earnings report?

Zoono Group Limited reported an EPS of -AU$0.001 in its last earnings report. Following the earnings report the stock price went down -5.769%.

Which hedge fund is a major shareholder of Zoono Group Limited?

Currently, no hedge funds are holding shares in AU:ZNO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Zoono Group Limited Stock Smart Score

Neutral

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description